Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
268.9 USD | +2.35% | +0.62% | -6.63% |
Apr. 19 | Wall Street: tech and SOXX in free fall this week | CF |
Apr. 17 | UBS Adjusts Amgen's Price Target to $284 From $314, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.63% | 141B | |
+24.60% | 672B | |
+24.08% | 550B | |
-5.63% | 351B | |
+15.37% | 317B | |
+7.38% | 292B | |
+3.26% | 211B | |
+0.78% | 203B | |
-9.69% | 144B | |
-3.20% | 113B |
- Stock Market
- Equities
- AMGN Stock
- News Amgen Inc.
- Amgen Reports Top-Line Results From Phase 3 Study of ABP 959, Biosimilar Candidate for Soliris